about
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.A functional landscape of resistance to ALK inhibition in lung cancer.Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions.Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma.Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2.Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer.Accuracy of the magnetic resonance imaging pathway in the detection of prostate cancer: a systematic review and meta-analysisThe utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysisUrinary Biomarkers in the Evaluation of Primary Hematuria: A Systematic Review and Meta-AnalysisTwitter-based Prostate Cancer Journal Club (#ProstateJC) Promotes Multidisciplinary Global Scientific Discussion and Research DisseminationDissemination of Misinformative and Biased Information about Prostate Cancer on YouTubeEpidemiology of genitourinary foreign bodies in the united states emergency room setting and its association with mental health disordersAssociation of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysisVariability in penile duplex ultrasound international practice patterns, technique, and interpretation: an anonymous survey of ISSM membersCurrent practice in the management of ischemic priapism: an anonymous survey of ISSM membersVariation in collagenase Clostridium histolyticum practice patterns: a Survey of ISSM Members
P50
Q27851728-F59F88FF-6887-45CC-BFAC-37873E5C4B87Q27851896-16B73F49-93EB-4C7E-9C8E-78B21FEB3F3EQ27852601-79883EDF-4F22-4F7D-9C05-CC6254DEBE55Q35438912-438B76F2-76A2-4E1F-B5F4-8A16B6A344F5Q36547123-B994E9AB-F93D-47F9-957B-8A8F580C69D1Q38831440-8895C0F2-98C4-4B26-BAE2-D0B7B1FF5C6EQ38903842-74D72262-6ED6-4D31-B13A-2A96854EFA8DQ39089944-B8C06589-D862-4C7B-95A9-5DC26070554FQ42826571-3D65B9C5-F401-4F79-B5D6-3F713ECA6F68Q53309223-46F4A214-3D1A-4BC6-B128-14119C58EEA0Q57107922-BC14C2A0-6665-48F3-8564-D515C2DCC183Q57109624-20036BCF-C5DB-4B8F-96D2-5C4900B553E9Q58705097-93AD0597-E285-44FC-B76F-8CC8C0CFD51DQ64117182-267C4784-1AF8-4109-8F01-361BC145DE90Q90013727-85C76DC2-CD0D-46B5-92D7-8F8CFC52F4F0Q90045777-FAB0213A-8574-45A8-9BA4-C821231AFFD8Q90863252-1D7F126A-C5CE-4AED-B3EF-4B501AA6BE7EQ90947518-FAF7D85D-6E6A-4B6C-AAAD-FA1F2195168DQ91341254-921C11BB-8065-45B9-8BED-9E6797D7A546Q91521008-63107800-DF9B-4BA2-8DF8-7F8F7FACE9B9
P50
description
researcher ORCID ID = 0000-0002-4760-4026
@en
name
Mohit Butaney
@ast
Mohit Butaney
@en
Mohit Butaney
@es
Mohit Butaney
@nl
type
label
Mohit Butaney
@ast
Mohit Butaney
@en
Mohit Butaney
@es
Mohit Butaney
@nl
prefLabel
Mohit Butaney
@ast
Mohit Butaney
@en
Mohit Butaney
@es
Mohit Butaney
@nl
P31
P496
0000-0002-4760-4026